SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    F Scheele, C.W Burger, P Kenemans, Postmenopausal hormone replacement in the woman with a reproductive risk factor for breast cancer, Maturitas, 1999, 33, 3, 191

    CrossRef

  2. 2
    Bo von Schoultz, HRT and breast cancer risk, what to advise?, European Journal of Obstetrics & Gynecology and Reproductive Biology, 1997, 71, 2, 205

    CrossRef

  3. 3
    Ingemar Persson, Cancer risk in women receiving estrogen-progestin replacement therapy, Maturitas, 1996, 23, S37

    CrossRef

  4. 4
    M. Birkhäuser, Hormonsubstitutionstherapie und Karzinogenese, European Surgery, 1996, 28, 5, 270

    CrossRef

  5. 5
    Loren Lipworth, Klea Katsouyanni, Sherri Stuver, Evangelia Samoli, Susan E. Hankinson, Dimitrios Trichopoulos, Oral contraceptives, menopausal estrogens, and the risk of breast cancer: A case-control study in greece, International Journal of Cancer, 1995, 62, 5
  6. 6
    Alastair J.J. Wood, Paul E. Belchetz, Hormonal Treatment of Postmenopausal Women, New England Journal of Medicine, 1994, 330, 15, 1062

    CrossRef

  7. 7
    Elizabeth Barrett-Connor, Postmenopausal estrogen and the risk of breast cancer, Annals of Epidemiology, 1994, 4, 3, 177

    CrossRef

  8. 8
    Barbara S. Hulka, Edison T. Liu, Ruth A. Lininger, Steroid hormones and risk of breast cancer, Cancer, 1994, 74, S3
  9. 9
    Thomas M. Mack, 7 Hormone replacement therapy and cancer, Baillière's Clinical Endocrinology and Metabolism, 1993, 7, 1, 113

    CrossRef

  10. 10
    Barnett Zumoff, Biological and endocrinological insights into the possible breast cancer risk from menopausal estrogen replacement therapy, Steroids, 1993, 58, 5, 196

    CrossRef

  11. 11
    Rena Vassilopoulou-Sellin, Estrogen replacement therapy in women at increased risk for breast cancer, Breast Cancer Research and Treatment, 1993, 28, 2, 167

    CrossRef

  12. 12
    W. James B. Smellie, J. Meirion Thomas, Hormone replacement therapy and breast cancer, BJOG: An International Journal of Obstetrics & Gynaecology, 1993, 100, 5
  13. 13
    M. Rautalahti, D. Albanes, J. Virtamo, J. Palmgren, J. Haukka, O. P. Heinonen, Lifetime menstrual activity ? Indicator of breast cancer risk, European Journal of Epidemiology, 1993, 9, 1, 17

    CrossRef

  14. 14
    Osteoporosis: Pathophysiology, prevention, diagnosis, and treatment, Disease-a-Month, 1993, 39, 11, 794

    CrossRef

  15. 15
    Carlo La Vecchia, Eva Negri, Silvia Franceschi, Fabio Parazzini, Non-contraceptive oestrogens and breast cancer: An update, International Journal of Cancer, 1992, 50, 1
  16. 16
    C.H. Van Aswegen, D.J. Du Plessis, The detachment cascade during metastasis, Medical Hypotheses, 1992, 39, 4, 364

    CrossRef

  17. 17
    Z. Kaufman, W.I.H. Garstin, R. Hayes, M.J. Michell, M. Baum, The mammographic parenchymal patterns of women on hormonal replacement therapy, Clinical Radiology, 1991, 43, 6, 389

    CrossRef

  18. 18
    Kate Hunt, Martin Vessey, The risks and benefits of hormone replacement therapy: an updated review, Current Obstetrics & Gynaecology, 1991, 1, 1, 21

    CrossRef

  19. 19
    Laura Hutchins, Ralph Broadwater, Nicholas P. Lang, Marinelle Bowie, Kent C. Westbrook, Breast cancer, Disease-a-Month, 1990, 36, 2, 67

    CrossRef

  20. 20
    Adami Hans-Olov, Adams Gerald, Boyle Peter, Ewertz Marianne, C. Lee Nancy, Lund Eiliv, B. Miller Anthony, Olsson Håkan, Steel Michael, Trichopoulos Dimitrios, Chapter II. Breast-Cancer Etiology, International Journal of Cancer, 1990, 46, S5
  21. 21
    I. Craig Henderson, What can a woman do about her risk of dying of breast cancer?, Current Problems in Cancer, 1990, 14, 4, 165

    CrossRef

  22. 22
    Elizabeth Barrett-Connor, Postmenopausal Estrogen Replacement and Breast Cancer, New England Journal of Medicine, 1989, 321, 5, 319

    CrossRef

  23. 23
    Brian E. Henderson, The cancer question: An overview of recent epidemiologic and retrospective data, American Journal of Obstetrics and Gynecology, 1989, 161, 6, 1859

    CrossRef

  24. 24
    Leif Bergkvist, Hans-Olov Adami, Ingemar Persson, Robert Hoover, Catherine Schairer, The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement, New England Journal of Medicine, 1989, 321, 5, 293

    CrossRef

  25. 25
    F.E. van Leeuwen, M.A. Rookus, The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer, European Journal of Cancer and Clinical Oncology, 1989, 25, 12, 1961

    CrossRef

  26. 26
    Virginia L. Ernster, Trudy L. Bush, George R. Huggins, Barbara S. Hulka, Jennifer L. Kelsey, David Schottenfeld, Benefits and risks of menopausal estrogen and/or progestin hormone use, Preventive Medicine, 1988, 17, 2, 201

    CrossRef

  27. You have free access to this content27
    Ikuko Kato, Suketami Tominaga, Tsuguyoshi Suzuki, Factors Related to Late Menopause and Early Menarche as Risk Factors for Breast Cancer, Japanese Journal of Cancer Research, 1988, 79, 2
  28. 28
    Marianne Ewertz, Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark, International Journal of Cancer, 1988, 42, 6
  29. 29
    David B. Thomas, Steroid hormones and medications that alter cancer risks, Cancer, 1988, 62, S1